NCT06748001 - Avapritinib Rollover Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 28, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Mastocytosis, Systemic

Interventions

DRUG

Avapritinib

Avapritinib will be administered in accordance with the parent study protocol.

Trial Locations (5)

RECRUITING

Universitair Ziekenhuis Antwerpen (UZA), Edegem

RECRUITING

Erasmus Medisch Centrum, Rotterdam

RECRUITING

A.O.U. San Giovanni di Dio e Ruggi d'Aragona di Salerno, Salerno

RECRUITING

Oslo University Hospital, Oslo

RECRUITING

Guys and St Thomas NHS Foundation Trust - St Thomas Hospital, London